Seeing Is Believing
Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (33.33%), 1 are a HOLD (11.11%), 5 are a BUY (55.56%).
Analyst Lyanne Harrison works at BAML with a stock forecast success ratio of 25% fulfilled within 16 days on average.
Lyanne Harrison’s has documented 18 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 17-Oct-2023.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $15.84 (8.09%) receiving and performance score of 26.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
224
$36.24 (19.30%)
215
18 days ago
5/7 (71.43%)
$34.68 (18.32%)
371
Buy
215
$27.24 (14.51%)
215
23 days ago
7/11 (63.64%)
$18.67 (9.51%)
66
Buy
205
$17.24 (9.18%)
185
2 months 20 days ago
5/11 (45.45%)
$14.1 (7.39%)
88
164
$-23.76 (-12.65%)
158
2 months 25 days ago
4/6 (66.67%)
$-21.88 (-11.77%)
30
Buy
207
$19.24 (10.25%)
2 months 25 days ago
4/5 (80%)
$21.12 (11.36%)
60
What Year was the first public recommendation made by Lyanne Harrison?